In the competitive field of Respiratory Drugs, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in Respiratory Drugs technology and learn how to protect your intellectual property.

Patent challenges are becoming increasingly common in the Respiratory Drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Respiratory Drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Respiratory Drugs industry

EP3973987Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistSANOFI BIOTECHNOLOGYOct 10, 2024LUIGI, RUMI
EP3973987Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistSANOFI BIOTECHNOLOGYOct 9, 2024SECERNA LLP
EP3973987Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALS, INC.Oct 1, 2024DR. H. ULRICH DORRIES
EP3703818Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALS, INC.Aug 1, 2024MICHALSKI HUTTERAMNN & PARTNER PATENTANWALTE MBB
EP3703818Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALS, INC.Jul 31, 2024HAMPTON KNOWLES LIMITED
EP3703818Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALS, INC.Jul 30, 2024BOULT WADE TENNANT LLP
EP3583947Streptococcus Pneumoniae Capsular Polysaccharides And Conjugates ThereofPFIZER INC.Jul 11, 2024SANOFI PASTEUR INC.
EP3500241Combination Therapy For CopdCHIESI FARMACEUTICI S.P.A.Jul 4, 2024ELKINGTON AND FIFE LLP
EP3500241Combination Therapy For CopdCHIESI FARMACEUTICI S.P.A.Jul 3, 2024HASELTINE LAKE KEMPNER LLP
EP3578169Pharmaceutical Formulations Comprising 4-{(1 R)-2-[(6-{2-[(2,6-Dichlorobenzyl)Oxy]Ethoxy}Hexyl)Amino]-1-Hydroxyethyl}-2-(Hydroxymethyl)PhenolGLAXO GROUP LIMITEDJun 27, 2024SANDOZ

To stay ahead in the competitive Respiratory Drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the Respiratory Drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Patent NumberGrant DateTitleApplicantTotal Oppositions
EP2637664Mar 29, 2017Compositions And Methods Of Treating Pulmonary HypertensionGILEAD SCIENCES, INC.10
EP2228064Dec 11, 2019Pharmaceutical Composition Containing Glycopyrrolate And A Beta2 Adrenoceptor AgonistNOVARTIS PHARMA GMBH10
EP2400950May 22, 2019Pharmaceutical Formulations Comprising 4-{(1R)-2- [(6-{2-[(2,6-Dichlorobenzyl)Oxy] Ethoxy}Hexyl)Amino]-1-Hydroxyethyl}-2- (Hydroxymethyl)PhenolGLAXO GROUP LIMITED8
EP3703818Nov 1, 2023Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALS, INC.7
EP2506850May 13, 2020Methods Of Administering Pirfenidone TherapyINTERMUNE, INC.6
EP3973987Jan 10, 2024Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistSANOFI BIOTECHNOLOGY6
EP2957551Jan 15, 2020Dry Powder Formulations Comprising VilanterolARVEN ILAC SANAYI VE TICARET A.S.4
EP3335708Dec 11, 2019Administration Of Gamma Hydroxybutyrate With Monocarboxylate TransportersJAZZ PHARMACEUTICALS IRELAND LIMITED4
EP2653162May 20, 2020Methods Of Administering Fluvoxamine TherapyINTERMUNE, INC.4
EP3053580Jun 30, 2021Method Of Providing Pirfenidone Therapy To A PatientINTERMUNE, INC.4